Literature DB >> 31020450

Operating characteristics of stepwise covariate selection in pharmacometric modeling.

Malidi Ahamadi1, Anna Largajolli2, Paul M Diderichsen2, Rik de Greef2, Thomas Kerbusch2, Han Witjes2, Akshita Chawla3, Casey B Davis3,4, Ferdous Gheyas3.   

Abstract

Stepwise covariate modeling (SCM) is a widely used tool in pharmacometric analyses to identify covariates that explain between-subject variability (BSV) in exposure and exposure-response relationships. However, this approach has several potential weaknesses, including over-estimated covariate effect and incorrect selection of covariates due to collinearity. In this work, we investigated the operating characteristics (i.e., accuracy, precision, and power) of SCM in a controlled setting by simulating sixteen scenarios with up to four covariate relationships. The SCM analysis showed a decrease in the power to detect the true covariates as model complexity increased. Furthermore, false highly correlated covariates were frequently selected in place of or in addition to the true covariates. Relative root mean square errors (RMRSE) ranged from 1 to 51% for the fixed effects parameters, increased with the number of covariates included in the model, and were slightly higher than the RMRSE obtained with a simple re-estimation exercise with the true model (i.e., stochastic simulation and estimation). RMRSE for BSV increased with the number of covariates included in the model, with a covariance parameter RMRSE of almost 135% in the most complex scenario. Loose boundary conditions on the continuous covariate power relation appeared to have an impact on the covariate model selection in SCM. A stricter boundary condition helped achieve high power (> 90%), even in the most complex scenario. Finally, reducing the sample size in terms of number of subjects or number of samples proved to have an impact on the power to detect the correct model.

Keywords:  Covariate analysis; NONMEM; Power; SCM; Stepwise model building

Year:  2019        PMID: 31020450     DOI: 10.1007/s10928-019-09635-6

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  12 in total

1.  Efficient screening of covariates in population models using Wald's approximation to the likelihood ratio test.

Authors:  K G Kowalski; M M Hutmacher
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-06       Impact factor: 2.745

2.  The effect of collinearity on parameter estimates in nonlinear mixed effect models.

Authors:  P L Bonate
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

3.  Building population pharmacokinetic--pharmacodynamic models. I. Models for covariate effects.

Authors:  J W Mandema; D Verotta; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1992-10

4.  Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis.

Authors:  Ulrika Wählby; E Niclas Jonsson; Mats O Karlsson
Journal:  AAPS PharmSci       Date:  2002

5.  Perl-speaks-NONMEM (PsN)--a Perl module for NONMEM related programming.

Authors:  Lars Lindbom; Jakob Ribbing; E Niclas Jonsson
Journal:  Comput Methods Programs Biomed       Date:  2004-08       Impact factor: 5.428

6.  Power, selection bias and predictive performance of the Population Pharmacokinetic Covariate Model.

Authors:  Jakob Ribbing; E Niclas Jonsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-04       Impact factor: 2.745

7.  PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

Authors:  Lars Lindbom; Pontus Pihlgren; E Niclas Jonsson; Niclas Jonsson
Journal:  Comput Methods Programs Biomed       Date:  2005-09       Impact factor: 5.428

8.  Automated covariate model building within NONMEM.

Authors:  E N Jonsson; M O Karlsson
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

Review 9.  Covariate selection in pharmacometric analyses: a review of methods.

Authors:  Matthew M Hutmacher; Kenneth G Kowalski
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

10.  The lasso--a novel method for predictive covariate model building in nonlinear mixed effects models.

Authors:  Jakob Ribbing; Joakim Nyberg; Ola Caster; E Niclas Jonsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-05-22       Impact factor: 2.410

View more
  3 in total

1.  Population Pharmacokinetics and Dosing Regimen of Lithium in Chinese Patients With Bipolar Disorder.

Authors:  Zi-Bin Jin; Zhuo Wu; Yi-Fan Cui; Xue-Peng Liu; Hong-Bo Liang; Jia-Yong You; Chen-Yu Wang
Journal:  Front Pharmacol       Date:  2022-07-04       Impact factor: 5.988

2.  Semi-Mechanistic Pharmacokinetic Model to Guide the Dose Selection of Nimotuzumab in Patients with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Niurys de Castro-Suárez; Mirjam N Trame; Mayra Ramos-Suzarte; José M Dávalos; Raymed A Bacallao-Mendez; Anaelys R Maceo-Sinabele; Víctor Mangas-Sanjuán; Gledys Reynaldo-Fernández; Leyanis Rodríguez-Vera
Journal:  Pharmaceutics       Date:  2020-11-26       Impact factor: 6.321

3.  Population Pharmacokinetic and Concentration-QTc Analysis of Delamanid in Pediatric Participants with Multidrug-Resistant Tuberculosis.

Authors:  Tomohiro Sasaki; Elin M Svensson; Xiaofeng Wang; Yanlin Wang; Jeffrey Hafkin; Mats O Karlsson; Suresh Mallikaarjun
Journal:  Antimicrob Agents Chemother       Date:  2021-11-29       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.